Literature DB >> 2378001

Ozone-induced bradycardia and arrhythmia and their relation to sleep-wakefulness in rats.

H Arito1, I Uchiyama, H Arakawa, E Yokoyama.   

Abstract

Rats were chronically implanted with electrodes for EEG, EMG and ECG recordings and exposed to 0.1 ppm, 0.2 ppm ozone (O3) or clean air as control for 5 consecutive days. Amounts of wakefulness (W), slow-wave sleep (SWS) and paradoxical sleep (PS) of the O3-exposed rats were not statistically different from respective control values. Compared with control rats, heart rates of the O3-exposed rats decreased and the number of bradyarrhythmic episodes increased with an increase in O3 levels. The O3-induced bradyarrhythmias occurred more prevalently in the order of W, SWS and PS state. Parasympathetic mechanisms were suggested on those cardiac abnormalities.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2378001     DOI: 10.1016/0378-4274(90)90151-b

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  4 in total

1.  Electroencephalographic and autonomic responses to trichloroethylene inhalation in freely moving rats.

Authors:  H Arito; M Takahashi; M Sotoyama; H Tsuruta; T Ishikawa
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

2.  Prenatal exposure to ozone disrupts cerebellar monoamine contents in newborn rats.

Authors:  Rigoberto Gonzalez-Pina; Carmen Escalante-Membrillo; Alfonso Alfaro-Rodriguez; Angelica Gonzalez-Maciel
Journal:  Neurochem Res       Date:  2007-11-22       Impact factor: 3.996

3.  Enhanced death signaling in ozone-exposed ischemic-reperfused hearts.

Authors:  Rama Surya Prakash Perepu; Carlos Garcia; David Dostal; Rajat Sethi
Journal:  Mol Cell Biochem       Date:  2009-10-03       Impact factor: 3.396

4.  Association between PM10 and O3 levels and hospital visits for cardiovascular diseases in Bangkok, Thailand.

Authors:  Dongruethai Buadong; Wanida Jinsart; Ikuko Funatagawa; Kanae Karita; Eiji Yano
Journal:  J Epidemiol       Date:  2009-06-13       Impact factor: 3.211

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.